Transcripts Bristol-Myers Squibb Company

Equities

BMY

US1101221083

Market Closed - Nyse Other stock markets 04:00:08 2024-05-17 pm EDT			5-day change	1st Jan Change
44.01 ^USD	-0.23%		-2.07%	-14.23%

May. 16	Everlasting momentum
May. 16	Bristol Myers Gets FDA OK of Breyanzi in Follicular Lymphoma	DJ

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Bristol-Myers Squibb Company Presents at Bank of America Health Care Conference 2024, May-15-2024 11:20 AM	May. 15
Transcript : Bristol-Myers Squibb Company Presents at Guggenheim Securities Radiopharmaceuticals Day, May-13-2024 11:00 AM	May. 13
Transcript : Bristol-Myers Squibb Company, Q1 2024 Earnings Call, Apr 25, 2024	Apr. 25
Transcript : Bristol-Myers Squibb Company Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-14-2024 08:30 AM	Mar. 14
Transcript : Bristol-Myers Squibb Company Presents at Leerink Partners Global Biopharma Conference 2024, Mar-13-2024 10:00 AM	Mar. 13
Transcript : Bristol-Myers Squibb Company Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-04-2024 09:50 AM	Mar. 04
Transcript : Bristol-Myers Squibb Company, Q4 2023 Earnings Call, Feb 02, 2024	Feb. 02
Transcript : Bristol-Myers Squibb Company Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 07:30 AM	Jan. 08
Transcript : Bristol-Myers Squibb Company Presents at Goldman Sachs Healthcare C-Suite Unscripted Conference, Jan-04-2024 11:00 AM	Jan. 04
Transcript : Bristol-Myers Squibb Company, Karuna Therapeutics, Inc. - M&A Call	Dec. 22
Transcript : Bristol-Myers Squibb Company Presents at 14th Annual Jefferies London Healthcare Conference 2023, Nov-16-2023 09:30 AM	Nov. 16
Transcript : Bristol-Myers Squibb Company Presents at UBS Biopharma Conference 2023, Nov-08-2023 08:00 AM	Nov. 08
Transcript : Bristol-Myers Squibb Company, Q3 2023 Earnings Call, Oct 26, 2023	23-10-26
Transcript : Bristol-Myers Squibb Company - Special Call	23-09-14
Transcript : Bristol-Myers Squibb Company Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-11-2023 08:00 AM	23-09-11
Transcript : Bristol-Myers Squibb Company, Q2 2023 Earnings Call, Jul 27, 2023	23-07-27
Transcript : Bristol-Myers Squibb Company Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-13-2023 08:40 AM	23-06-13
Transcript : Bristol-Myers Squibb Company Presents at Jefferies 2023 Global Healthcare Conference, Jun-08-2023 09:00 AM	23-06-08
Transcript : Bristol-Myers Squibb Company Presents at 2023 American Society of Clinical Oncology Annual Meeting, Jun-02-2023 through Jun-06-2023	23-06-01
Transcript : Bristol-Myers Squibb Company Presents at Bank of America Securities 2023 Healthcare Conference, May-09-2023 08:40 AM	23-05-09

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Christopher Boerner, CEO of Bristol-Myers: A pipeline of 16 treatments, with a focus on neuroscience and oncology

January 09, 2024 at 01:06 pm EST